Market Overview: Colorectal Cancer   26-page PDF document
$299.00

Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Log in to unlock full preview.
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Market Overview: Colorectal Cancer (26-page PDF document) Preview Image
Arrow   Click main image to view in full screen. Unlock all 9 preview images:   Login Register

Market Overview: Colorectal Cancer – PDF

PDF document 26 Pages

$299.00

Add to Cart
  


Immediate download
Editable with PDF editor
Free lifetime updates

BENEFITS OF THIS DOWNLOADABLE PDF DOCUMENT

  1. Colorectal cancer therapy market will grow modestly from $8.4 billion in 2015 to $12.5 billion in 2025
  2. Etiology and Pathophysiology
  3. Market Overview

ONCOLOGY PDF DESCRIPTION

Colorectal cancer market overview (PDF): Download market size, forecast, drug launches, immune checkpoint inhibitors (Keytruda, Tecentriq) and market drivers. Market Overview: Colorectal Cancer is a 26-page PDF document available for immediate download upon purchase.

The colorectal cancer therapy market will grow modestly from $8.4 billion in 2015 to $12.5 billion in 2025 in the seven major pharmaceutical markets under study. Growth will be fueled by continued uptake of premium-priced therapies and the approval of six emerging therapies. In 2025, immune checkpoint inhibitors will hold an impressive 33% share of this market.

Two immune checkpoint inhibitors are expected to launch for colorectal cancer (Merck & Co.'s Keytruda [pembrolizumab] and Roche/Genentech/Chugai's Tecentriq [atezolizumab]), significantly contributing to the aforementioned market growth. Their combined major-market sales will total approximately $4.2 billion in 2025, driven largely by the two agents: approval in MSI-H and dMMR patient populations.

Introduction
Key Findings
Market Share of Cancer Drug Classes in 2015 and 2025
Market SWOT Analysis
Etiology and Pathophysiology
Key Findings
Expert Insight
Pathophysiology
Anatomy
Subtypes
Staging and Classification
Key Pathways and Drug Targets
Market Outlook
Key Findings
Expert Insight
Market Overview
Market Drivers and Constraints
What Factors Are Driving the Market?
What Factors Are Constraining the Market?

Got a question about the product? Email us at support@flevy.com or ask the author directly by using the "Ask the Author a Question" form. If you cannot view the preview above this document description, go here to view the large preview instead.

Source: Best Practices in Oncology PDF: Market Overview: Colorectal Cancer PDF (PDF) Document, pharmzolgas


$299.00

Add to Cart
  

ABOUT THE AUTHOR

Author: pharmzolgas
Additional documents from author: 3

Ask the Author a Question

You must be logged in to contact the author.

Click here to log in Click here register

Did you know?
The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.




Trusted by over 10,000+ Client Organizations
Since 2012, we have provided business templates to over 10,000 businesses and organizations of all sizes, from startups and small businesses to the Fortune 100, in over 130 countries.
AT&T GE Cisco Intel IBM Coke Dell Toyota HP Nike Samsung Microsoft Astrazeneca JP Morgan KPMG Walgreens Walmart 3M Kaiser Oracle SAP Google E&Y Volvo Bosch Merck Fedex Shell Amgen Eli Lilly Roche AIG Abbott Amazon PwC T-Mobile Broadcom Bayer Pearson Titleist ConEd Pfizer NTT Data Schwab





Read Customer Testimonials

 
"As a consultant requiring up to date and professional material that will be of value and use to my clients, I find Flevy a very reliable resource.

The variety and quality of material available through Flevy offers a very useful and commanding source for information. Using Flevy saves me time, enhances my expertise and ends up being a good decision."

– Dennis Gershowitz, Principal at DG Associates
 
"Flevy is now a part of my business routine. I visit Flevy at least 3 times each month.

Flevy has become my preferred learning source, because what it provides is practical, current, and useful in this era where the business world is being rewritten.

In today's environment where there are so "

– Omar Hernán Montes Parra, CEO at Quantum SFE
 
"Last Sunday morning, I was diligently working on an important presentation for a client and found myself in need of additional content and suitable templates for various types of graphics. Flevy.com proved to be a treasure trove for both content and design at a reasonable price, considering the time I "

– M. E., Chief Commercial Officer, International Logistics Service Provider
 
"I have used Flevy services for a number of years and have never, ever been disappointed. As a matter of fact, David and his team continue, time after time, to impress me with their willingness to assist and in the real sense of the word. I have concluded in fact "

– Roberto Pelliccia, Senior Executive in International Hospitality
 
"[Flevy] produces some great work that has been/continues to be of immense help not only to myself, but as I seek to provide professional services to my clients, it gives me a large "tool box" of resources that are critical to provide them with the quality of service and outcomes they are expecting."

– Royston Knowles, Executive with 50+ Years of Board Level Experience
 
"As an Independent Management Consultant, I find Flevy to add great value as a source of best practices, templates and information on new trends. Flevy has matured and the quality and quantity of the library is excellent. Lastly the price charged is reasonable, creating a win-win value for "

– Jim Schoen, Principal at FRC Group
 
"As a small business owner, the resource material available from FlevyPro has proven to be invaluable. The ability to search for material on demand based our project events and client requirements was great for me and proved very beneficial to my clients. Importantly, being able to easily edit and tailor "

– Michael Duff, Managing Director at Change Strategy (UK)
 
"Flevy is our 'go to' resource for management material, at an affordable cost. The Flevy library is comprehensive and the content deep, and typically provides a great foundation for us to further develop and tailor our own service offer."

– Chris McCann, Founder at Resilient.World



Customers Also Like These Documents

Explore Templates on Related Management Topics



Your Recently Viewed Documents
Download our FREE Strategy & Transformation Framework Templates

Download our free compilation of 50+ Strategy & Transformation slides and templates. Frameworks include McKinsey 7-S, Balanced Scorecard, Disruptive Innovation, BCG Curve, and many more.